Several absolute and relative measures useful to assess the consequences of treatments in cancer research are presented together with statistical methods suitable for computing the pertinent confidence intervals. The relationship of these measures with the parameters of the regression models commonly used in the analysis of survival data is elaborated upon. Three examples are elaborated, and conditions of interchangeability of the measures are discussed in detail. Finally, suggestions for the choice of the measure most appropriate for a specified data set are given.
Get full access to this article
View all access options for this article.
References
1.
BaileyB.J.R.: Confidence limits to the risk ratio. Biometrics, 43: 201–205, 1987.
2.
BennettS.: Analysis of survival data by the proportional odds model. Stat. Med., 2: 273–277, 1983.
BerksonJ., GageR.P.: Calculation of survival rates for cancer. Staff Meet. Mayo Clinic, 25: 270–286, 1950.
5.
CampbellM.J., GardnerM.J.: Calculating confidence intervals for some non-parametric analyses. Br. Med. J., 296: 1454–1456, 1988.
6.
CoxD.R.: Regression models and life tables (with discussion). J.R. Statis. Soc. B., 34: 187–220, 1972.
7.
Early Breast Cancer Trialists' Collaborative Group:Effects of adjuvant tamoxifen and cytotoxic therapy on mortality in early breast cancer. An overview of randomized trials among 28,896 women. New Engl. J. Med., 319: 1681–1692, 1988.
8.
FiellerE.C.: The biological standardization of insulin. J.R. Stat. Soc., Supplement, 7: 1–64, 1940.
9.
FleissJ.L.: Statistical methods for rates and proportions.John Wiley and Sons, New York, 1981.
10.
FreireichE.J., GehanE.A., FreiE.III, SchroederL.R., WolmanI.J., AnbariR., BurgertE.O., MillsS.D., PinkelD., SelawryO.S., MoonJ.H., GendelB.R., SpurrC.L., StorrsR., HauraniF., HoogstratenB., LeeS.: The effect of 6-mercaptopurine on the duration of steroid induced remission in acute leukemia. Blood, 21: 699–716, 1963.
11.
GardnerM.J., AltmanD.G.: Confidence intervals rather than P values: estimation rather than hypothesis testing. Br. Med. J., 292: 746–750, 1986.
12.
GartJ.J., NamJ.M.: Approximate interval estimation of the ratio of binomial parameters: a review and corrections for skewness. Biometrics, 44: 323–338, 1988.
13.
GehanE.A.: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika, 52: 203–223, 1965.
14.
GoreS.M., PocockS.J., KerrG.R.: Regression models and non-proportional hazard in the analysis of breast cancer survival. Appl. Stat., 33: 176–195, 1984.
15.
KalbfleischJ.D., PrenticeR.L.: The statistical analysis of failure time data.John Wiley and Sons, New York, 1980.
16.
KaplanE.L., MeierP.: Non parametric estimation from incomplete observations. J. Am. Stat. Ass., 53: 457–481, 1958.
17.
LaupacisA., SackettD.L., RobertsR.S.: An assessment of clinically useful measures of the consequences of treatment. New Engl. J. Med., 26: 1728–1733, 1988.
18.
LawlessJ.F.: Statistical models and methods for lifetime data.John Wiley and Sons, New York, 1982.
19.
MantelN.: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163–170, 1966.
20.
MarubiniE., ValsecchiM.G.: Analisi della sopravvivenza in sperimentazioni cliniche controllate e nelle osservazioni pianificate. Monografia n. 9 del Centro Zambon dell'Università degli Studi di Milano, 1987.
21.
MezzanotteG., BoracchiP., ValagussaP., MarubiniE.: Analisi della sopravvivenza a lungo termine nel carcinoma mammario. Riv. Stat. Appl., 20: 251–267, 1987.
22.
MorrisJ.A., GardnerM.J.: Calculating confidence intervals for relative risks (odds ratios) and standardized ratios and rates. Br. Med. J., 296: 1313–1316, 1988.
23.
PetoR., PikeM.C., ArmitageP., BreslowN.E., CoxD.R., HowardS.V., MantelN., McPhersonK., PetoJ., SmithP.G.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient - II. Analysis and examples. Br. J. Cancer, 35: 1–39, 1977.
24.
Powell-TuckJ., McRacK.D., HealyM.J.R., Lennard-JonesJ.E., ParkinsR.A.: A defence of the small clinical trial: evaluation of three gastroenterological studies. Br. Med. J., 292: 599–602, 1986.
25.
SackettD.L.: Inference and decision at the bedside. J. Clin. Epidemiol., 42: 309–316, 1989.
26.
SimonR.: Confidence intervals for reporting results of clinical trials. Ann. Intern. Med., 105: 429–435, 1986.
